GAN (GAN) Competitors

Health Catalyst (NASDAQ:HCAT) and GAN (NASDAQ:GAN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

Which has more volatility and risk, HCAT or GAN?

Health Catalyst has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500. Comparatively, GAN has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500.

Does the MarketBeat Community prefer HCAT or GAN?

Health Catalyst received 152 more outperform votes than GAN when rated by MarketBeat users. Likewise, 67.63% of users gave Health Catalyst an outperform vote while only 33.33% of users gave GAN an outperform vote.

Company	Underperform	Outperform
Health Catalyst	Outperform Votes 163 67.63%	Underperform Votes 78 32.37%
GAN	Outperform Votes 11 33.33%	Underperform Votes 22 66.67%

Is HCAT or GAN more profitable?

GAN has a net margin of -9.84% compared to Health Catalyst's net margin of -26.20%. GAN's return on equity of 0.00% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-26.20%	-7.51%	-3.72%
GAN	-9.84%	N/A	-15.85%

Do institutionals and insiders believe in HCAT or GAN?

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 16.7% of GAN shares are owned by institutional investors. 2.5% of Health Catalyst shares are owned by company insiders. Comparatively, 8.5% of GAN shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the media prefer HCAT or GAN?

In the previous week, Health Catalyst had 1 more articles in the media than GAN. MarketBeat recorded 5 mentions for Health Catalyst and 4 mentions for GAN. Health Catalyst's average media sentiment score of 1.41 beat GAN's score of 0.24 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GAN	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable earnings & valuation, HCAT or GAN?

GAN has lower revenue, but higher earnings than Health Catalyst. GAN is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$306.58M	1.02	-$118.15M	-$1.15	-3.89
GAN	$135.00M	0.60	-$34.44M	-$0.18	-9.78

Do analysts rate HCAT or GAN?

Health Catalyst currently has a consensus target price of $9.27, indicating a potential upside of 107.44%. Given Health Catalyst's stronger consensus rating and higher probable upside, analysts clearly believe Health Catalyst is more favorable than GAN.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
GAN	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Health Catalyst beats GAN on 12 of the 18 factors compared between the two stocks.